Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 5.32% | 76.06 | 6.2% | $205.22m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -10.38% | 18.04 | 14.1% | $106.15m | |
| CTLT | Catalent, Inc. | -0.03% | 88.16 | 2.2% | $89.17m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.78% | 126.08 | 2.4% | $76.67m | |
| BHC | Bausch Health Cos., Inc. | -10.38% | 18.04 | 0.0% | $75.32m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | -3.33% | 1.16 | 0.5% | $57.52m | |
| PRGO | Perrigo Co. Plc | -0.02% | 50.45 | 6.8% | $45.46m | |
| ARGX | argenx SE | -0.15% | 230.76 | 0.0% | $42.63m | |
| GWPH | GW Pharmaceuticals Plc | -17.21% | 109.37 | 6.2% | $42.38m | |
| ICLR | ICON plc | 0.30% | 189.91 | 4.3% | $41.81m | |
| PCRX | Pacira Biosciences, Inc. | 0.38% | 58.35 | 10.3% | $39.85m | |
| AMRN | Amarin Corp. Plc | -0.71% | 7.00 | 1.5% | $39.83m | |
| MYOK | MyoKardia, Inc. | 3.12% | 103.40 | 1.8% | $38.76m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 3.33% | 48.75 | 16.8% | $38.58m | |
| UTHR | United Therapeutics Corp. | 0.53% | 112.79 | 14.1% | $37.15m |
Company Profile
CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.